Hsiangkuo Yuan Selected Research

Hsiangkuo Yuan Research Topics

17	Migraine Disorders (Migraine) 04/2024 - 01/2015
9	Pain (Aches) 04/2024 - 01/2016
8	Headache (Headaches) 03/2024 - 01/2015
7	Breast Neoplasms (Breast Cancer) 06/2013 - 10/2011
6	Neoplasms (Cancer) 01/2018 - 07/2012
4	Headache Disorders (Headache Syndromes) 04/2024 - 01/2021
3	Neurogenic Inflammation 01/2022 - 12/2017
3	Brain Neoplasms (Brain Tumor) 07/2019 - 04/2014
2	Cluster Headache (Cluster Headaches) 10/2020 - 01/2019
2	Inflammation (Inflammations) 03/2016 - 01/2016
1	Chronic Pain 04/2024
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2023
1	Coronary Vasospasm (Coronary Artery Vasospasm) 10/2023
1	Ganglion Cysts (Ganglion) 01/2023
1	Nervous System Diseases (Neurological Disorders) 05/2022
1	Photophobia (Light Sensitivity) 10/2021
1	Hyperacusis (Phonophobia) 10/2021
1	Vomiting 10/2021
1	Gastroparesis 10/2021
1	Hypersensitivity (Allergy) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Asthma (Bronchial Asthma) 03/2016
1	Photosensitivity Disorders (Photodermatitis) 06/2013
1	Hyperthermia 11/2012

8	Calcitonin Gene-Related PeptideIBA 04/2024 - 12/2017
8	GoldIBA 07/2019 - 02/2012
7	NeuropeptidesIBA 05/2022 - 12/2017
6	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 04/2024 - 12/2017
6	Monoclonal AntibodiesIBA 04/2024 - 12/2017
3	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2022 - 12/2017
2	Amino Acids FDA Link 05/2022 - 01/2022
2	Botulinum Toxins (Botulinum Toxin)IBA 01/2021 - 01/2021
2	erenumabIBA 01/2019 - 11/2018
1	ubrogepantIBA 03/2024
1	Ketamine FDA LinkGeneric 12/2023
1	Tryptamines (Triptans)IBA 10/2023
1	Dihydroergotamine (Agit)FDA LinkGeneric 10/2023
1	atogepantIBA 01/2022
1	Meloxicam (Mobic)FDA LinkGeneric 10/2021
1	Ibuprofen (Motrin)FDA LinkGeneric 10/2021
1	KetorolacIBA 10/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2021
1	Type A Botulinum Toxins (Botox)FDA Link 01/2021
1	NeurotoxinsIBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2020
1	fremanezumabIBA 01/2019
1	eptinezumabIBA 01/2019
1	galcanezumabIBA 01/2019
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2018
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2018
1	Vasodilator Agents (Vasodilators)IBA 12/2017
1	CatecholaminesIBA 03/2016
1	Opioid Analgesics (Opioids)IBA 03/2016
1	InflammasomesIBA 01/2015
1	Surface-Active Agents (Surfactants)IBA 01/2015
1	Menthol FDA Link 01/2015
1	Peptides (Polypeptides)IBA 06/2013
1	Silicon Dioxide (Silica)FDA LinkGeneric 02/2013
1	GraphiteIBA 11/2012
1	Wheat Germ AgglutininsIBA 02/2012
1	Contrast MediaIBA 02/2012
1	Singlet OxygenIBA 10/2011

12	Therapeutics 04/2024 - 07/2012
5	Lasers (Laser) 01/2015 - 10/2011
3	Vagus Nerve Stimulation 10/2020 - 01/2016
3	Precision Medicine 01/2018 - 06/2013
2	Drug Therapy (Chemotherapy) 01/2022 - 11/2021
2	Photothermal Therapy 01/2018 - 01/2015
1	Microvascular Decompression Surgery 01/2023
1	Deep Brain Stimulation 01/2023
1	Immunotherapy 01/2018
1	Photochemotherapy (Photodynamic Therapy) 06/2013